Literature DB >> 18550941

Hypertension in women--part II.

Priscilla Igho Pemu1, Elizabeth Ofili.   

Abstract

In Part I, we reviewed the pathophysiology of hypertension in women. This section focuses on the treatment of hypertension in special circumstances and special populations: pregnancy, preeclampsia, and lactation; hypertension in black women; and hypertension in the elderly.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18550941      PMCID： PMC2922044          DOI： 10.1111/j.1751-7176.2008.08337.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


  16 in total

1.  Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.

Authors:  Björn Dahlöf; Peter S Sever; Neil R Poulter; Hans Wedel; D Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Journal:  Lancet       Date:  2005 Sep 10-16       Impact factor: 79.321

2.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

3.  Hypertension in adults across the age spectrum: current outcomes and control in the community.

Authors:  Donald M Lloyd-Jones; Jane C Evans; Daniel Levy
Journal:  JAMA       Date:  2005-07-27       Impact factor: 56.272

Review 4.  Women and hypertension: what did we learn from the Women's Health Initiative?

Authors:  Suzanne Oparil
Journal:  Cardiol Rev       Date:  2006 Nov-Dec       Impact factor: 2.644

Review 5.  Hypertension in women: current understanding of gender differences.

Authors:  S N Hayes; S J Taler
Journal:  Mayo Clin Proc       Date:  1998-02       Impact factor: 7.616

6.  Morehouse Community Physicians Network (CPN) hypertension registry: patterns of care and opportunities for targeted medical education.

Authors:  Priscilla Igho-Pemu; Alexander Quarshie; Adefisayo Oduwole; Rigobert Lapu-Bula; Robert Mayberry; Chamberlain Obialo; Gary H Gibbons; Elizabeth Ofili
Journal:  Ethn Dis       Date:  2005       Impact factor: 1.847

7.  Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.

Authors:  Stevo Julius; Sverre E Kjeldsen; Michael Weber; Hans R Brunner; Steffan Ekman; Lennart Hansson; Tsushung Hua; John Laragh; Gordon T McInnes; Lada Mitchell; Francis Plat; Anthony Schork; Beverly Smith; Alberto Zanchetti
Journal:  Lancet       Date:  2004-06-19       Impact factor: 79.321

Review 8.  Hypertension in women.

Authors:  Michel E Safar; Harold Smulyan
Journal:  Am J Hypertens       Date:  2004-01       Impact factor: 2.689

Review 9.  Characteristics and treatment of hypertension in women: a review of the literature.

Authors:  C E Lewis
Journal:  Am J Med Sci       Date:  1996-04       Impact factor: 2.378

10.  Enhanced vasoreactivity and its response to antihypertensive therapy in hypertensive elderly women.

Authors:  Lewis A Lipsitz; Ikechukwu Iloputaife; Margaret Gagnon; Dan K Kiely; Jorge M Serrador
Journal:  Hypertension       Date:  2006-01-30       Impact factor: 10.190
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.